Colorado Springs, CO5 Active Studies

Crohns Disease Clinical Trials in Colorado Springs, CO

Find 5 actively recruiting crohns disease clinical trials in Colorado Springs, CO. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
1,933
Enrolling

Recruiting Crohns Disease Studies in Colorado Springs

RecruitingColorado Springs, CONCT06548542

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms i...

500 participants
AbbVie
View Study Details
RecruitingColorado Springs, CONCT06819891

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also known as RO7790121) in participants with moderately...

425 participants
Hoffmann-La Roche
View Study Details
RecruitingColorado Springs, CONCT06581328

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this stud...

400 participants
Takeda
View Study Details
RecruitingColorado Springs, CONCT06227910

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to ved...

396 participants
Takeda
View Study Details
RecruitingColorado Springs, CONCT06456593

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the efficacy and safety of obefazimod compared t...

212 participants
Abivax S.A.
View Study Details

About Crohns Disease Clinical Trials in Colorado Springs

Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.

There are currently 5 crohns disease clinical trials recruiting participants in Colorado Springs, CO. These studies are seeking a combined 1,933 participants. Research is being sponsored by AbbVie, Hoffmann-La Roche, Takeda and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Crohns Disease Clinical Trials in Colorado Springs — FAQ

Are there crohns disease clinical trials in Colorado Springs?

Yes, there are 5 crohns disease clinical trials currently recruiting in Colorado Springs, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What crohns disease treatments are being tested?

The 5 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.

Data updated March 2, 2026 from ClinicalTrials.gov